lung-cancer

Documents about lung-cancer

• CAR T Cell Receptor Immunotherapy Targeting Mesothelin for Patients With Metastatic Cancer#267998ClinicalTrials.gov
• SRS Timing With Immune Checkpoint Inhibition in Patients With Untreated Brain Metastases From Non-small Cell Lung Cancer#18604ClinicalTrials.gov
• Exploration of Risk Factors for Postoperative Cerebral Infarction in Lung Cancer Patients: a Retrospective Single-centre Study#28477ClinicalTrials.gov
• CIK Cell Transfusion Plus Gefitinib As Second Or Third-Line Treatment for Advanced Adenocarcinoma Non-Small Cell Lung Cancer#160367ClinicalTrials.gov
• Phase I Study of Individualized Neoantigen Peptides in the Treatment of EGFR Mutant Non-small Cell Lung Cancer#181771ClinicalTrials.gov
• Vaccine Therapy Plus Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer That Has Been Completely Removed in Surgery#238123ClinicalTrials.gov
• Atezolizumab in Elderly Patients With Advanced Non-Small-Cell Lung Cancer and Receiving Carboplatin Paclitaxel Chemotherapy#252971ClinicalTrials.gov
• Sequential Chemo-immunotherapy Plus Thoracic Radiotherapy for Elderly And/or Frail Stage III Non-small-cell Lung Cancer#256875ClinicalTrials.gov
• Vaccine Therapy in Treating Patients With Non-Small Cell Lung Cancer (NSCLC) Stages IIIB/IV#283104ClinicalTrials.gov
• Anlotinib Combined With Penpulimab as Front-line Treatment in Advanced Non-small Cell Lung Cancer#311129ClinicalTrials.gov
• A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS)#414386ClinicalTrials.gov
• Feasibility Trial of a Personalised Nutrition and Activity Programme for People With Lung Cancer Over 65 Years#125868ClinicalTrials.gov
• Toripalimab Combined With Chemotherapy as Adjuvant Therapy for Incidental Small Cell Lung Cancer After Radical Resection of Lung Cancer: A Single-Center, Randomized Controlled Clinical Study Protocol Number: LungMate-033#141000ClinicalTrials.gov
• Pembrolizumab and Stereotactic Body Radiation Therapy or Non-Stereotactic Wide-Field Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer#208447ClinicalTrials.gov
• Bronchoscopy With Bronchoalveolar Lavage in Identifying Biomarkers of Response to Immune Checkpoint Inhibitors in Patients With Non-small Cell or Small Cell Lung Cancer#377424ClinicalTrials.gov
• ARGONAUT: Stool and Blood Sample Bank for Cancer Patients#121332ClinicalTrials.gov
• Microwave Ablation Plus Tislelizumab and Docetaxel in Advanced NSCLC After First-Line Immunotherapy Failure#136302ClinicalTrials.gov
• Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial#136323ClinicalTrials.gov
• Guangzhou Women's Health Cohort Study (GWHCS)#146323ClinicalTrials.gov
• A Trial With Chemotherapy, Immunotherapy, and Radiotherapy for Patients With Newly Diagnosed Stage IV Small Cell Lung Cancer#18602ClinicalTrials.gov
• Early Specialized Cardiovascular Intervention Based on Impedance Cardiography in Locally Advanced Non-small Cell Lung Cancer Patients#127588ClinicalTrials.gov
• The Addition of Ipilimumab to Carboplatin and Etoposide Chemotherapy for Extensive Stage Small Cell Lung Cancer#184865ClinicalTrials.gov
• Golidocitinib for Refractory Immune-related Hematologic Toxicities of Advanced Lung Cancer#249585ClinicalTrials.gov
• A Study to Investigate Atezolizumab Subcutaneous in Patients With Previously Treated Locally Advanced or Metastatic Non-Small Cell Lung Cancer#303719ClinicalTrials.gov
• Immunological effects of amivantamab in EGFR or MET-expressing non-small cell lung cancer#309401OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• LUNG CANCER TREND ANALYSIS, RISK PREDICTION MODELS, AND COST-EFFECTIVENESS OF SCREENING PROGRAMS IN SINGAPORE#334549ScholarBank@NUS
• IBI310 (Anti-CTLA-4) in Combination With Sintilimab in Patients With Non-small-cell Lung Cancer (NSCLC)#394766ClinicalTrials.gov
• Application of 68Ga-labeled ACE2 Targeting Probe PET/CT Imaging in Tracing ACE2 Expression and Diagnosis of Lung Cancer#405215ClinicalTrials.gov
• Ramucirumab and Atezolizumab After Progression on Any Immune Checkpoint Blocker in NSCLC#417561ClinicalTrials.gov
• SHR-1701 Combined With Fluzoparib in Lung Squamous Cell Carcinoma#226238ClinicalTrials.gov
• Preoperative Sintilimab Combined With Bevacizumab and Chemotherapy for Resectable Non-Small Cell Lung Cancer#238091ClinicalTrials.gov
• IMMUNO-LUNG : Identification of Biomarkers and Therapeutic Targets for Pulmonary Immunotherapy#343834ClinicalTrials.gov
• Single-section multiplexed imaging enables comprehensive lung cancer diagnosis#221561bioRxiv / medRxiv
• Cardiopulmonary Toxicity of Thoracic Radiotherapy#332854ClinicalTrials.gov
• Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies#283056ClinicalTrials.gov
• Vaccine Therapy in Treating Patients With Liver or Lung Metastases From Colorectal Cancer#300245ClinicalTrials.gov
• PD-L2 Targeting Nanobody Radiotracer for PET Imaging of Solid Tumor#377416ClinicalTrials.gov
• QUILT-3.038: Active Immunotherapy CEA Vaccine in Patients With Malignancies Expressing CEA#146479ClinicalTrials.gov
• Supplementation of n-3 PUFA in the Modulation of Lean Mass in Patients With Lung Cancer Receiving a High-protein Diet#146432ClinicalTrials.gov
• Mechanism of Response to IMFINZI Neoadjuvant Therapy in Non-small Cell Lung Cancer Patients Based on Multiple-omics Models#154666ClinicalTrials.gov
• Novel risk models based on screening history results and timing of lung cancer diagnosis: Post hoc analysis of the National Lung Cancer Screening Trial#180170bioRxiv / medRxiv
• Phase 2 Study of MPDL3280A Combined With CDX-1401 in NY-ESO 1 (+) IIIB, IV or Recurrent Non-Small Cell Lung Cancer#369885ClinicalTrials.gov
• A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer#424179ClinicalTrials.gov
• Characteristics of lung nodules detected by low-dose CT scan: Results from the French lung cancer screening study DEP KP-80#161178HAL (France)
• Adjuvant Benmelstobart for Stage IB, Grade 3 Invasive Lung Adenocarcinoma#303722ClinicalTrials.gov
• Impact on Quality of Life From Multi-modality Lung Cancer#307463ClinicalTrials.gov
• VX15/2503 in Combination With Avelumab in Advanced Non-small Cell Lung Cancer#407713ClinicalTrials.gov
• Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer#28305ClinicalTrials.gov
• Autologous Natural Killer T Cells Infusion for the Treatment of Cancer#28337ClinicalTrials.gov
• Preneoplasia of lung cancer#153464PMC Full-Text (OAI)